glp 1 receptor agonist for weight loss Anti-obesity drugs are closing the gap between dieting and bariatric surgery | Diet and Nutrition | Prevention Mechanisms of GLP-1 Receptor Agonist-Induced
Description
Finan, B
Ongoing clinical trials are currently investigating a single-dose regimen of Danuglipron for managing overweight and obesity (NCT04616339)
Those with a personal or family history of multiple endocrine neoplasia syndrome type 2 (MEN2)
2011;34(Suppl 2):S279-S284
M., Govers, R
